HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vehicle-Based Drug Photosensitivity Testing Discouraged By CTFA

This article was originally published in The Rose Sheet

Executive Summary

Photosensitivity testing of reformulated topical drugs is unnecessary and should not be encouraged by FDA, the Cosmetic, Toiletry and Fragrance Association advises in recent comments on the agency's draft guidance on photosafety testing.

You may also be interested in...



NTP Retinyl Palmitate Phototoxicity Studies Opposed By L'Oreal

Mechanistic tests of topical cosmetic ingredient retinyl palmitate would be more useful than proposed phototoxicity research, according to L'Oreal Research Corporate Toxicology Director Esther Patrick, PhD.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007964

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel